Circulation. 123 (2011): 266–73.
Li, J., et al. “Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease.” Neurology 76 (2011): 1485–91.
Lin, F. R., et al. “Hearing loss and incident dementia.” Arch Neurol. 68 (2011): 214–20.
Reitz, C., et al. “Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of lateonset Alzheimer disease.” Arch Neurol 67 (2010): 1491–97.
Bettermann, K., et al. “Statins, risk of dementia, and cognitive function: Secondary analysis of the Ginkgo Evaluation of Memory Study.” J Stroke Cerebrovasc Dis 12 Jan 2011.website TK
De Felice, F. G., et al. “Protection of synapses against Alzheimer’s-linked toxins: Insulin signaling prevents the pathogenic binding of A_ oligomers.” Proc Natl Acad Sci USA 106 (2009): 1971–76.
Szekely, C. A., et al. “No Advantage of A_42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies.” Neurology 70 (2008): 2291–98.
Small, G. W., and L. F. Jarvik. “The dementia syndrome.” Lancet 2 (1982): 1443–46.
Radimer, K., et al. “Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999–2000.” Am J Epidemiol 160 (2004): 339–49.
Small, G. W. “Beyond standard anti-dementia therapies: Diet, exercise, socialization, and supplements: CNS Spectrums 13 (Suppl 16) (2008): 31–33
Usharani, P., et al. “Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study.” Drugs R D 9 (2008): 243–50.
Hubbard, W. K. “Letter updating the phosphatidylserine and cognitive function and dementia qualified health claim.” FDA U.S. Department of Health and Human Services. November 24, 2004. http://www.fda.gov/Food/LabelingNutrition/LabelClaims/QualifiedHealth- Claims/ucm072993.htm.
Vakhapova, V., et al. “Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in nondemented elderly with memory complaints: a double-blind placebo-controlled trial.” Dement Geriatr Cogn Disord 29 (2010): 467–74.
Kato-Kataoka, A., et al. “Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints.” J Clin Biochem Nutr 47 (2010): 246–55.
Honein, M. A., et al. “Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects.” JAMA 285 (2001): 2981–86.
Hooshmand. B., et al. “Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study.” Neurology 75 (2010): 1408–14.
Riggs, K. M., et al. “Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study.” Am J Clin Nutr 63 (1996): 306–14
Smith, A. D., et al. “Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.” PLoS One 5 (2010): e12244.
Politis, A., et al. “Vitamin B12 levels in Alzheimer’s disease: association with clinical features and cytokine production.” J Alzheimers Dis 19 (2010): 481–88.
Iwamoto, J., et al. “Prevention of hip fractures by exposure to sunlight and pharmacotherapy in patients with Alzheimer’s disease.” Aging Clin Exp Res 21 (2009): 277–81.
Annweiler, C., et al. “Vitamin D and ageing: neurological issues.” Neuropsychobiology 62 (2010): 139–50.
Llewellyn, D. J., et al. “Vitamin D and risk of cognitive decline in elderly persons.” Arch Intern Med 170 (2010): 1135–41.
Annweiler, C., et al. “Dietary intake of vitamin D and cognition in older women: a large population-based study.” Neurology 75 (2010): 1810–16.
Sano, M., et al. “A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease.” N Engl J Med. 336 1997: 1216–22.
Miller, E. R., et al. “Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality.” Ann Int Med 142 (2005): 37–46.
Devore, E. E., et al. “Dietary antioxidants and long-term risk of dementia.” Arch Neurol 67 (2010): 819–25.
Gray, S. L., et al. “Antioxidant vitamin supplement use and risk of dementia or Alzheimer’s disease in older adults.” J Am Geriatr Soc 56 (2008): 291–95.
DeKosky, S. T., et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial.” JAMA 300 (2008): 2253–62.
Lopez, L. B., et al. “High dietary and plasma levels of the omega-3 fatty acid docosahexaenoic acid are associated with decreased dementia risk: the Rancho Bernardo study.” J Nutr Health Aging 15 (2011): 25–31.
Quinn, J. F., et al. “Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.” JAMA 304 (2010): 1903–11.
Scholey, A., et al. “Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo- controlled, crossover study.” Psychopharmacology 212 (2010): 345–56.
Geng, J., et al. “Ginseng for cognition.” Cochrane Database Syst Rev 8 Dec 2010. 12:CD007769.
Small, G. W. “Alzheimer’s disease and other dementing disorders,” in Comprehensive Textbook of Psychiatry, 9th ed., B. J. and V. A. Sadock, eds. Williams & Wilkins (Baltimore: 2009), pp. 4058–65.
Petersen, R. C., et al. “Vitamin E and donepezil for the treatment of mild cognitive impairment.” N Engl J Med 352 (2005): 2379–88.
Schneider, L. S., et al. “Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer’s Disease Neuroimaging Initiative.” Arch Neurol 68 (2011): 58–66.
Silverman, D.H.S., et al. “Long-term effects of donepezil versus placebo on regional brain metabolism in minimally impaired subjects.” Alzheimer’s Association International Conference on Alzheimer’s Disease (ICAD), 2008.
Ferris, S., et al. “A double-blind, placebo-controlled trial of memantine in age-associated memory impairment (memantine in AAMI).” Int J Geriatr Psychiatry 22 (2007): 448–55.
Nixon, R. A., and D. S. Yang. “Autophagy failure in Alzheimer’s disease: locating the primary defect.” Neurobiol Dis 3 Feb 2011.
Nelson, L. D., et al. “PET of brain amyloid and tau in adults with Down syndrome.” Arch Neurol 68 (2001): 768–74.
Lu, P. H., et al. “Donepezil delays progression to AD in MCI subjects with depressive symptoms.” Neurology 72 (2009): 2115–21.
Mayberg, H. S. “Modulating dysfunctional limbic-cortical circuits in depression: Towards development of brain-based algorithms for diagnosis and optimised treatment.” Br Med Bull 65 (2003): 19–207.
Lally, P., et al. “How are habits formed: Modelling habit formation in the real world.” Eur J Soc Psychol 2010; 40: 998–1009.
Sarkisian, C. A., et al. “Pilot test of an attribution retraining intervention to raise walking levels in sedentary older adults.” J Am Geriatr Soc 55 (2007): 1842–46.
Lang, P. J., et al. “Emotion, motivation, and anxiety: Brain mechanisms and psychophysiology.” Biol Psychiatry 44 (1998): 1248–63.
Savine, A. C., and T. S. Braver. “Motivated cognitive control: reward incentives modulate preparatory neural activity during task-switching.” J Neurosci 30 (2010): 10, 294–305.
Dijkstra, K., et al. “Body posture facilitates retrieval of autobiographical memories.” Cognition 102 (2007): 139–49.
Ybarra, O., et al. “Mental exercising through simple socializing: social interaction promotes general cognitive functioning.” Pers Soc Psychol Bull 34 (2008): 248–59.
Sarkisian, C. A., et al. “Pilot test of an attribution retraining intervention to raise walking levels in sedentary older adults.” J Am Geriatr Soc 55 (2007): 1842–46.
Pope, S. K., et al. “Will a healthy lifestyle help prevent Alzheimer’s disease?” Ann Rev Public Health 42 (2003): 111–32.
Yang, K., et al. “Outcomes of health care providers’ recommendations for healthy lifestyle among U.S. adults with prediabetes.” Metab Syndr Relat Disord 9 (2011): 231-37.
Adams, C. E., and M. R. Leary. “Promoting self-compassionate attitudes toward eating among restrictive and guilty eaters.” J Soc Clin Psych 26 (2007): 1120–44.
Sol, B. G., et al. “The effect of self-efficacy on cardiovascular lifestyle.” Eur J Cardiovasc Nurs 29 Jul 2010.
http://www.sciencedirect.com/science/article/pii/S1474515110000812.
Yon, B. A., et al. “Personal digital assistants are comparable to traditional diaries for dietary self-monitoring during a weight loss program.”J Behav Med 30 (2007): 165–75.
Burke, L. E., et al. “Self-monitoring in weight loss: a systematic review of the literature.” J Am Diet Assoc 111 (2011): 92–102.
Honea, R. A., et al. “Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease.” Neurology 74 (2010): 113–20.
Mosconi, L., et al. “Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease.” Neurology 72 (2009): 513–20.
Frisardi, V., et al. “Aluminum in the diet and Alzheimer’s disease: from current epidemiology to possible disease-modifying treatment.” J Alzheimers Dis. 20 (2010): 17–30.
Rondeau, V., et al. “Aluminum and silica in drinking water and the risk of Alzheimer’s disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort.”